Last November, the Brussels Court of First Instance handed down a decision on the scope of protection conferred by SPCs. The case relates to a vinorelbine tartrate SPC and whether or not the scope of protection conferred by an SPC extends to the use of an active ingredient as such before it is transformed into a medicinal product.
The details can be read here.
No comments:
Post a Comment